Jarrow Formulas' Probiotics Contain Clinically Documented Strains
GR-1Ⓡ/RC-14® and VAGINAL FLORÁ (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
Box contains smaller, Activ-Vial™ moisture-controlled desiccant bottle for better stability of probiotic bacteria.
Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1®+ and Limosilactobacillus reuteri RC-14®+, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.
‡Updates based on official taxonomy reclassification.
For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.
Maltodextrin (non-GMO source), vegetarian capsule (hydroxypropylmethylcellulose, titanium dioxide), cellulose and magnesium stearate (vegetable source).
Free of major allergens.
Keep refrigerated.
Keep out of the reach of children.
| Поживна цінність | ||
| Serving Size: 1 Capsule | ||
| Servings Per Container: 30 | ||
| Amount Per Serving | % DV | |
| Total Probiotic Blend Composed of the following strains: Lactobacillus rhamnosus, GR-1† Lactobacillus reuteri, RC-14† | 5 billion viable cells | †† |
| ††Daily Value not established. †Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others. | ||